{
    "organizations": [],
    "uuid": "74305f44cadfbd76f67ba23a50872a34618dc705",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSL5N1QR200",
    "ord_in_thread": 0,
    "title": "BRIEF-OncoArendi Therapeutics Plans IPO In March/April",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9 (Reuters) - ONCOARENDI THERAPEUTICS SA ( IPO-ORT.WA ):\n* PLANS INITIAL PUBLIC OFFERING IN MARCH/APRIL * UNDER OFFER COMPANY WILL ISSUE NO LESS THAN 500,000 AND NO MORE THAN 2 MILLION NEW SHARES\n* INTENDS TO ALLOCATE ABOUT 90% OF OFFERED SHARES TO INSTITUTIONAL INVESTORS AND ABOUT 10% TO RETAIL INVESTORS\n* TRIGON DOM MAKLERSKI IS INTERMEDIARY IN OFFER * COMPANY SPECIALIZES IN DEVELOPMENT AND COMMERCIALIZATION OF NEW DRUGS USED IN TREATMENT OF CANCERS AND RESPIRATORY DISEASES\n* INFORMED ABOUT PLANNED DEBUT ON WARSAW STOCK EXCHANGE IN DEC, 2017\nSource text: bit.ly/2HfVjfx\nFurther company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-09T18:03:00.000+02:00",
    "crawled": "2018-03-10T20:12:13.040+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "oncoarendi",
        "therapeutic",
        "sa",
        "plan",
        "initial",
        "public",
        "offering",
        "offer",
        "company",
        "issue",
        "less",
        "million",
        "new",
        "share",
        "intends",
        "allocate",
        "offered",
        "share",
        "institutional",
        "investor",
        "retail",
        "investor",
        "trigon",
        "dom",
        "maklerski",
        "intermediary",
        "offer",
        "company",
        "specializes",
        "development",
        "commercialization",
        "new",
        "drug",
        "used",
        "treatment",
        "cancer",
        "respiratory",
        "disease",
        "informed",
        "planned",
        "debut",
        "warsaw",
        "stock",
        "exchange",
        "dec",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}